CPHI Milan 2026: Three Manufacturing Questions We’re Watching
30 September 2026.CPHI Milan opens next week with manufacturing under growing scrutiny across the pharmaceutical industry.
Connecting drone and UAV manufacturers with operators across multiple domains.
Where the automotive industry reveals the next generation of mobility.
CPHI Milan opens next week with manufacturing under growing scrutiny across the pharmaceutical industry.
The global Antibody Drug Conjugates market is projected to grow at a CAGR of 11.8% by 2036
High on the list is what is happening in the powering space
Britain reshapes battlefield reconnaissance with AR5 and smaller tactical drones
The global Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is projected to grow at a CAGR of 9.0% by 2036
Clinical trials are getting harder to run as complexity increases
The market is valued at US$652.89 billion in 2026 and is projected to reach US$2,103.43 billion by 2036, expanding at a 12.4% CAGR
Visiongain has launched an independent primary research study examining the capabilities, requirements and constraints shaping US drone manufacturing.
Counter-UAS procurement shifts towards integrated systems, common standards and scale
Specialist pharma capacity remains constrained by format, qualification and demand
Small drones are reshaping defence through layered, affordable counter-UAS strategies
Commercial site transfers reshape CDMO growth, revenue timing and value
Britain tests faster counter-drone procurement as lasers and integration advance
Faster trials increase demand for flexible, resilient clinical supply networks
Australia’s defence build-up tests industry, supply chains and delivery capacity
US pharma investment shifts toward strategic, complex, domestic manufacturing capacity
Washington expands missile production, but rebuilding depleted inventories takes years
CDMO competition shifts toward specialist capacity, geography and selective outsourcing
The global Clinical Trial Supply and Logistics Market for Pharma is projected to grow at a CAGR of 8.7% by 2036
The global market is expected to expand from US$9.91bn in 2026 to US$41.58bn by 2036, at a 15.4% CAGR